BCL2 and myeloid sarcoma: have shown that apoptosis is disturbed and dysregulated in T cells of MS patients; also, the expression level of FLIP and Bcl-2 proteins increases compared to the control group, making T cells resistant to apoptosis and remain self-reactive (10).